1239034-70-8

Basic information

• Product Name: 4-(2-Methyl-l,2^,4-tetrahydro-pyrido[4,3-6]indol-5-ylmethyl)beiizoic acid methyl ester
• Synonyms: 4-(2-Methyl-l,2^,4-tetrahydro-pyrido[4,3-6]indol-5-ylmethyl)beiizoic acid methyl ester;4-(2-Methyl-l,2^,4-tetrahydro-pyrido[4,3-6]indol-;Methyl 4-((2-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)methyl)benzoate
• CAS NO: 1239034-70-8
• Molecular Formula: C₂₁H₂₂N₂O₂
• Molecular Weight: 334.41158
• Mol File: 1239034-70-8.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 4-(2-Methyl-l,2^,4-tetrahydro-pyrido[4,3-6]indol-5-ylmethyl)beiizoic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(2-Methyl-l,2^,4-tetrahydro-pyrido[4,3-6]indol-5-ylmethyl)beiizoic acid methyl ester(1239034-70-8)
• EPA Substance Registry System: 4-(2-Methyl-l,2^,4-tetrahydro-pyrido[4,3-6]indol-5-ylmethyl)beiizoic acid methyl ester(1239034-70-8)

Safety Data

• Hazardous Substances Data: 1239034-70-8(Hazardous Substances Data)

Upstream product

• 5094-12-2 2-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole 
• 14273-90-6 methyl 6-bromohexanoate 
• 100-63-0 phenylhydrazine 
• 1445-73-4 1-Methyl-4-piperidone 

Downstream Products

• 1239262-52-2 N-hydroxy-4-(2-methyl-1,2,3,4-tetrahydro-pyrido[4,3-b]indol-5-ylmethyl)benzamide trifluoroacetic acid salt 
• 1252003-15-8 tubastatin A 

Relevant articles and documents

HDAC6 inhibitor accelerates wound healing by inhibiting tubulin mediated IL-1β secretion in diabetic mice

Delayed wound healing in diabetes is characterized by sustained activation of inflammasome and increased expression of IL-1β in macrophages. Identification and validation of novel pathways to regulate IL-1β expression will provide therapeutic targets for